Recrutamento encerrado
FASE
Número Europeu 2021-003672-14
CAAA601A52101
A Phase Ib Dose Finding Study Assessing Safety and Activity of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Radiotherapy With or Without Temozolomide and in Recurrent Glioblastoma as Single Agent
Detalhes
Destaques